AI Workforce ROI Auditor
Separates gross time gain from review, correction and rework; examines quality and full costs. Capacity estimates remain separate from realized cash savings.
PsychFlo / Investor overview
Live platform · Seeking first customers
PsychFlo helps HR and Finance compare retention outcomes, inspect uncertainty and prepare an investment review grounded in evidence.
PsychFlo is seeking its first sales. Product demonstrations show the workflow; they are not customer outcomes or evidence of revenue.
The public demo uses synthetic data. Observed differences are not causal proof; financial scenarios are not verified savings.
Company information is supplied by PsychFlo. The buyer and commercial approach are hypotheses, not evidence of sold pilots.
The problem
A turnover dashboard describes a change. A decision about continuing, expanding, modifying or stopping an initiative also needs a suitable comparison, aligned observation windows, costs and an explanation of uncertainty.
Which retention investments are worth continuing? Could the observed change reflect something other than the intervention? How do costs compare with plausible outcomes?
PsychFlo brings the comparison, assumptions and limitations into one documented workflow so leadership can review what supports a recommendation and what remains unknown.
The working product / Retention Intervention Lab
See the working product
Compare outcomes, inspect uncertainty and explore financial assumptions in the interactive demonstration. No registration or company data is required.
Synthetic example data illustrates the workflow. It does not establish customer adoption, verified savings or a causal effect.
Specify the population, observation periods and decision to support.
Document the initiative, reference group and suitability of the comparison.
Inspect turnover rates, absolute differences, uncertainty and data-quality warnings.
Vary costs and assumed avoided departures; keep hypothetical value separate from observed outcomes.
Export calculations, assumptions, limitations and next steps for human review.
The demonstration is available without an account. Changing intervention labels does not create different evidence. Organizational imports and saved records require authorized access.
Separates gross time gain from review, correction and rework; examines quality and full costs. Capacity estimates remain separate from realized cash savings.
Compares workload, capacity and cost assumptions with reproducible seeded scenarios. Simulation percentiles are not observed workforce outcomes.
Commercial validation
Open for first customer purchases
PsychFlo is seeking its first sales. Product demonstrations show the workflow; they are not customer outcomes or evidence of revenue.
Customer identities, evaluation details and commercial terms remain confidential.
Commercial activity is company-reported unless separately evidenced. Company identities and private feedback remain confidential. A confidentiality agreement does not establish adoption, payment or results.
These are definitions, not a claim that any stage has been achieved. Demonstrations are not counted as signed pilots.
Product differentiation
Organize a comparison around a defined initiative, population and observation period rather than stopping at descriptive metrics.
Review uncertainty, source data, quality warnings, missingness and methodological limitations alongside the result.
Explore intervention costs and conditional financial scenarios without presenting modeled value as realized savings.
What happened?
What happened, what supports the comparison, which assumptions matter, and what should be reviewed before deciding?
This compares questions and workflows, not competitor feature sets. Differentiation and defensibility remain subject to customer validation.
Buyer and business model hypothesis
Start with one retention initiative, approved aggregate observations, a meaningful comparison, documented costs and an accountable decision owner. Buyer fit and procurement requirements must be established through actual customer conversations.
Agree the question, data, deliverables, limitations, success criteria and commercial terms.
Review whether the report supports a real decision and improves the customer’s current workflow.
Assess whether another intervention evaluation is valuable and practical to deliver.
Consider a continuing agreement only if repeat usefulness and commercial terms are established.
Commercial pricing, conversion rates, and repeat-use economics remain under validation.
Review the existing scoped pilot approach →Market thesis / to be validated
This is a market hypothesis, not measured demand. No market-size estimate, validated urgency or procurement budget is asserted.
Technical credibility
Bounded aggregate CSV imports, required mappings, numeric and date checks, population constraints and data-quality warnings.
Observed rates and differences, documented approximate uncertainty intervals, and small-cell and complementary suppression.
Explicit intervention and replacement-cost assumptions; hypothetical avoided departures remain separate from observed differences.
PDF and CSV reports carry calculations, scenario assumptions, limitations and methodology for review.
Authorized organizational access, immutable calculation snapshots, independent approval and audit history in saved workflows.
The software supports evaluation and documented review. It does not establish causation or automatically decide employment outcomes.
The application uses Next.js, React and TypeScript, deployed on Cloudflare Workers with D1 storage. Shared calculation code powers the public synthetic demonstration and organizational evaluation workflows.
Retention comparisons use a conservative approximate 95% difference interval from Bonferroni-adjusted marginal 97.5% Wilson score limits. This is an approximate statistical calculation, not external validation of a predictive model.
Missing data, small samples, comparison suitability and aligned periods affect interpretation. A difference in outcomes alone does not establish an intervention effect. Scenario assumptions do not convert an observed association into proven avoided departures.
No proprietary trained model, external predictive validity, regulatory certification or independent security certification is claimed.
Evidence and limitations
Inspect the working product separately from synthetic examples, company reports, operational records and future plans.
Demonstrated product capability
Synthetic demonstration evidence
Current commercial status
Operational database records
Proposed commercial milestones
Independent evidence: no independently verified customer outcomes, financial savings or external certification are presented in this briefing. Dates are shown only where a source supplies them.
Historical operational records reflect activity captured in the connected system at the stated date. Confidential commercial discussions may be maintained separately and are not represented by these counters.
Snapshot as of . Source: Cloudflare D1: read-only production aggregate query. This is a dated snapshot, not a live counter or an independent audit.
This historical operational snapshot does not determine current revenue status. Current financial claims require reconciled payment evidence.
These operational records do not establish signed commitments, paying customers or measured customer outcomes. Paying customers and MRR are unavailable without reconciled contracts and billing records.
Inspect the unchanged aggregate source record →Independent methods, privacy, security and customer-outcome validation remain diligence priorities. Internal tests and a functional demonstration are not substitutes for those reviews.
Pilot-to-revenue milestones
Define one question, NDA restrictions, separate data-processing requirements, deliverables and decision criteria.
Invite authorized users; validate approved aggregate data, observation periods and comparison suitability.
Save an evaluation, export a report and document whether it helped the customer make a decision.
Record formal agreements separately from verified receipts. Interest and commitment never substitute for payment.
Observe repeat analysis, actual follow-up and delivery effort before proposing ongoing terms or scale claims.
These describe the evaluation process, not a count of completed engagements. Preserve customer feedback, purchasing commitments, payment records and delivery effort separately; reported validation does not establish recurring revenue or sustainable economics.
Product roadmap / proposed
| Priority | Evidence required |
|---|---|
| Validate the buyer | Recorded decision problems, alternatives, buying authority, budget ownership and explicit next actions. |
| Deliver useful evaluations | Agreed scope, suitable data, reviewed reports and customer feedback; verified payment evidence before revenue claims. |
| Establish repeat use | A second evaluation, completed outcome reviews, delivery effort and continuing commercial terms. |
| Strengthen enterprise readiness | Independent methodology/privacy/security review, prospective validation and capacity evidence. |
| Prioritize integrations | Specific customer requirements and justified delivery costs before committing to new integrations. |
Investor FAQ
PsychFlo helps HR and Finance teams evaluate workforce interventions, inspect observed differences and uncertainty, and explore conditional financial scenarios before deciding what to do next.
The initial buyer hypothesis is an HR or People leader working with Finance to evaluate one retention initiative. Buying authority, budget ownership and willingness to pay remain under validation.
The Retention Intervention Lab connects intervention configuration, observed outcome comparisons, financial assumptions and a documented decision report. Supporting ROI and organizational simulation capabilities already exist alongside it.
Yes. The public demonstration runs the shared calculations on labeled synthetic data and supports report exports. Authorized organizational workspaces support saved evaluations and review workflows. This does not establish external validity or customer outcomes.
The founder reports no sales to date. PsychFlo is seeking its first paying customers. Working demos and available checkout do not establish customer adoption, revenue or independent commercial validation.
Agree one decision question, an authorized data scope, a suitable comparison, deliverables, limitations, success criteria and commercial terms before starting. Review the report with the customer and assess usefulness. The existing pilot offer depends on data readiness; observation and follow-up can require longer.
Its proposed differentiation is a joined workflow around an intervention, inspectable assumptions and financial decision support. This describes the product design, not a claim that competitors lack these features or that a commercial moat is established.
The application implements documented observed-rate comparisons and approximate uncertainty intervals, with shared calculation code, internal tests and a synthetic demonstration. Methodology is available to inspect. No independent customer-outcome or predictive validation is presented.
Observational differences do not prove causation. Small samples, missingness, unsuitable comparisons and timing can limit interpretation. Financial scenarios depend on assumptions, and synthetic examples do not validate outcomes. Repeat use, scalability and sustainable economics require ongoing measurement.
PsychFlo’s commercial approach is scoped enterprise evaluations with the option to agree ongoing software access. Pricing and terms depend on scope; repeat-use economics require ongoing measurement.
Validate the buyer and decision problem, agree pilot scope and data requirements, deliver reviewed evaluations, reconcile any payment evidence and test repeat use. Customer-justified integrations and independent reviews are future priorities, not completed achievements.
Next step
Review PsychFlo’s working demonstration, methodology, and proposed enterprise pilot approach.
Contact PsychFlo via support@psychflo.com
Agree scope before sharing data. Do not submit employee-level or health information in the inquiry form. No investment, accelerator acceptance or financial outcome is guaranteed.